Literature Review: Factors Associated with the Incidence of Diabetic Retinopathy in Patients with Type II Diabetes Mellitus
Abstract
Diabetes Mellitus (DM) type II is a metabolic disorder caused by insulin resistance in muscle and liver cells, as well as pancreatic beta cell failure. Diabetic retinopathy is one of the diseases that is a microvascular complication of the retina due to chronic hyperglycemia in patients with Type II DM. Chronic hyperglycemia in patients with type 2 DM can change the physiology and biochemistry of cells, resulting in endothelial damage. In this condition, various biochemical pathways are activated, and this affects the occurrence of 4 pathophysiologies of diabetic retinopathy. Several risk factors suspected of triggering diabetic retinopathy are age, duration of disease, poor blood sugar control or hyperglycemia and blood pressure, dyslipidemia, hyperviscosity, kidney failure, anemia, and smoking. Blood sugar control is the most dominant risk factor for diabetic retinopathy among other factors in patients with type II DM. Based on the background, the author is interested in conducting research on risk factors that influence the incidence of diabetic retinopathy. The purpose of this study was to determine the risk factors that influence the incidence of diabetic retinopathy. The research conducted was a Literature Review with a Narrative Review design. Based on the search results, 7 relevant articles were obtained for use in this Narrative Review. The conclusion is that the risk factors suspected of causing diabetic retinopathy include the duration of diabetes mellitus, uncontrolled blood sugar levels, and Type II DM patients with hypertension or dyslipidemia.
References
Adrian, D. (2017). Pengaruh Anti-VEGF pada Diabetic Retinopathy. Cermin Dunia Kedokteran Edisi 258, 44(11), 809–813. https://doi.org/10.55175/cdk.v44i11.705
Ansari, P., Tabasumma, N., Snigdha, N. N., Siam, N. H., Panduru, R. V. N. R. S., Azam, S., Hannan, J. M. A., et al. (2022). Diabetic Retinopathy: An Overview on Mechanisms, Pathophysiology and Pharmacotherapy. Diabetology, 3(1), 159–175. https://doi.org/10.3390/diabetology3010011
Ansari, P., Tabasumma, N., Snigdha, N. N., Siam, N. H., Panduru, R. V., Azam, S., ... & Abdel-Wahab, Y. H. (2022). Diabetic retinopathy: an overview on mechanisms, pathophysiology and pharmacotherapy. Diabetology, 3(1), 159-175. https://doi.org/10.3390/diabetology3010011
Bilal, A., Sun, G., Li, Y., Mazhar, S., & Khan, A. Q. (2021). Diabetic retinopathy detection and classification using mixed models for a disease grading database. IEEe Access, 9, 23544-23553. https://doi.org/10.1109/ACCESS.2021.3056186
Chauke, M. M. (2023). Possible correlations between HbA1c and selected modifiable risk factors for type 2 diabetes mellitus in a non-diabetic population. University of Johannesburg (South Africa).
Dewi, P. N., Fadrian, F., & Vitresia, H. (2019). Profil Tingkat Keparahan Retinopati Diabetik Dengan Atau Tanpa Hipertensi pada di RSUP Dr. M. Djamil Padang. Jurnal Kesehatan Andalas, 8(2), 204. http://dx.doi.org/10.25077/jka.v8.i2.p204-210.2019
El-Metwally, A., Fatani, F., Binhowaimel, N., Al Khateeb, B. F., Al Kadri, H. M., Alshahrani, A., ... & Alangari, A. S. (2023). Effect modification by age and gender in the correlation between diabetes mellitus, hypertension, and obesity. Journal of Primary Care & Community Health, 14, 21501319231220234. https://doi.org/10.1177/21501319231220234
Geany, P. L., Prihatningtias, R., Wildan, A., & Cahyono, M. (2022). Correlation between HbA1c Levels and Severity of Diabetic Retinopathy. DIPONEGORO MEDICAL JOURNAL (Jurnal Kedokteran Diponegoro), 11(5), 231–236. https://doi.org/10.14710/dmj.v11i5.35569
Grzybowski, A., Markeviciute, A., & Zemaitiene, R. (2021). Treatment of macular edema in vascular retinal diseases: a 2021 update. Journal of clinical medicine, 10(22), 5300. https://doi.org/10.3390/jcm10225300
Harini, I. M., Setyanto, M. R., Gumilas, N. S. A., & Ernawati, D. A. (2022). Hubungan antara Profil Lipid dengan Kejadian Retinopati Diabetika pada Pasien Diabetes Melitus Tipe 2 di Fasilitas Kesehatan Tingkat Pertama Klinik Tanjung Purwokerto. Jurnal Kesehatan Andalas, 11(1), 14.
Hertapanndika, Eka, I. W., Nandya, I., Sutyawan, E., Triningrat, & Putrawati, A. . M. (2020). Profil Retinopati Diabetik Di Divisi Vitreo–Retina Rumah Sakit Umum Pusat Sanglah Denpasar 1 Januari–30 Juni 2015. Jurnal Medika Udayana, 9(3), 32–38. Retrieved from https://ojs.unud.ac.id/index.php/eum/article/view/59906
Jawa, A., Kcomt, J., & Fonseca, V. A. (2004). Diabetic nephropathy and retinopathy. Medical Clinics, 88(4), 1001-1036. https://doi.org/10.1016/j.mcna.2004.04.012
Kakiay, A., & Wigiyanti. (2022). Jurnal Riset Ilmiah. Jurnal Riset Ilmiah, 1(01), 15–18.
Keenum, Z., McGwin, G., Witherspoon, C. D., Haller, J. A., Clark, M. E., & Owsley, C. (2016). Patients’ adherence to recommended follow-up eye care after diabetic retinopathy screening in a publicly funded county clinic and factors associated with follow-up eye care use. JAMA ophthalmology, 134(11), 1221-1228. https://doi.org/10.1001/jamaophthalmol.2016.3081
Mulyani, L. D., & Ridwan, A. A. (2020). Gambaran Faktor Risiko Diabetes Melitus Tipe 2 dengan Komplikasi Retinopati Diabetik pada Pasien Rawat jalan di RSUD Al Ihsan Tahun 2017-2019. Prosiding Kedokteran, 6(1), 300–305. https://doi.org/10.62335/sinergi.v2i2.863
Occhiutto, M. L., Freitas, F. R., Maranhao, R. C., & Costa, V. P. (2012). Breakdown of the blood-ocular barrier as a strategy for the systemic use of nanosystems. Pharmaceutics, 4(2), 252–275. https://doi.org/10.3390/pharmaceutics4020252
Patil, N. S., Mihalache, A., Hatamnejad, A., Popovic, M. M., Kertes, P. J., & Muni, R. H. (2023). Intravitreal steroids compared with anti-VEGF treatment for diabetic macular edema: a meta-analysis. Ophthalmology Retina, 7(4), 289-299. https://doi.org/10.1016/j.oret.2022.10.008
PERDAMI. (2018). Pedoman Nasional Pelayanan Kedokteran Retinopati Diabetika. Perdami, 6–26. Retrieved from https://perdami.or.id/wp-content/uploads/2022/03/Panduan-Nasional-Pelayanan-Kedokteran-Retinopati-Diabetik.pdf
Pongsachareonnont, P. F., Sakthong, P., Chaikitmongkol, V., Tsutsumi, W. D., Bhoomibunchoo, C., Hurst, C. P., ... & Kulvichit, K. (2024). Health Utility Values Among Patients With Diabetic Retinopathy, Wet Age-Related Macular Degeneration, and Cataract in Thailand: A Multicenter Survey Using Time Trade-Off, EQ-5D-5L, and Health Utility Index 3. Value in Health Regional Issues, 44, 101030. https://doi.org/10.1016/j.vhri.2024.101030
Purnama, R. F. N. (2023). Retinopati Diabetik : Manifestasi Klinis, Diagnosis, Tatalaksana dan Pencegahan. Lombok Medical Journal, 2(1), 39–42. https://doi.org/10.29303/lmj.v2i1.2410
Rübsam, A., Parikh, S., & Fort, P. E. (2018). Role of inflammation in diabetic retinopathy. International Journal of Molecular Sciences, 19(4), 1–31. https://doi.org/10.3390/ijms19040942
Salamah, S., Syaja'ah, K. N., & Perkasa, Y. S. (2022). Severity Classification of Non-Proliferative Diabetic Retinopathy Using Support Vector Machine (SVM). Jurnal Penelitian Fisika dan Aplikasinya (JPFA), 12(2), 167-179. https://doi.org/10.26740/jpfa.v12n2.p167-179
Sardarinia, M., Asgari, S., Hizomi Arani, R., Eskandari, F., Azizi, F., Khalili, D., & Hadaegh, F. (2022). Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: more than a decade follow up in the Tehran lipids and glucose study. Journal of Diabetes Investigation, 13(2), 317-327. https://doi.org/10.1111/jdi.13647
Sasongko, M. B., Febryanto, G. A., Supanji, Wardhana, F. S., Lestari, Y. D., Puspita, A., & Widyaputri, F. (2025). Incidence and progression of diabetic retinopathy and blindness in Indonesian adults with type 2 diabetes. medRxiv, 2025-03. https://doi.org/10.1101/2025.03.18.25324213
Shaniaputri, T., Iskandar, E., & Fajriansyah, A. (2022). Prevalensi Retinopati Diabetik di Puskesmas di Bandung Raya Periode Januari 2019-Desember 2020. eJournal Kedokteran Indonesia, 10(1), 39–45. https://doi.org/10.23886/ejki.10.119.39-45
Siddiqui, K., George, T. P., Joy, S. S., & Alfadda, A. A. (2022). Risk factors of chronic kidney disease among type 2 diabetic patients with longer duration of diabetes. Frontiers in Endocrinology, 13, 1079725. https://doi.org/10.3389/fendo.2022.1079725
Sinaga, M. R. B., Yensuari, Y., & Dharma, S. (2023). Pengaruh Kendali Glukosa Darah, Hipertensi, Dan Dislipidemia Terhadap Komplikasi Retinopati Diabetik Pada Penderita Diabetes Melitus Tipe 2. Jurnal Multidisiplin Indonesia, 2(10), 3304-3319. https://doi.org/10.58344/jmi.v2i10.608
Soelistijo, S. (2021). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021. Global Initiative for Asthma, 46. Retrieved from www.ginasthma.org.
Sri Irmandha K. (2021). WAL’AFIAT HOSPITAL JOURNAL Hubungan Jenis Retinopati Diabetik dengan Lama Menderita Diabetes Melitus dan Kadar HbA1C, 1(1), 8–16. Retrieved from http://whj.umi.ac.id/index.php/whj
Suman, S., Tiwari, A. K., & Singh, K. (2023). Automatic grading of non-proliferative diabetic retinopathy. Research on Biomedical Engineering, 39(3), 677-692. http://dx.doi.org/10.1007/s42600-023-00298-4
Thapa, R., Khanal, S., Tan, H. S., Thapa, S. S., & van Rens, G. H. M. B. (2020). Prevalence, pattern and risk factors of retinal diseases among an elderly population in nepal: The bhaktapur retina study. Clinical Ophthalmology, 14, 2109–2118. https://doi.org/10.2147/opth.s262131
Ulfayani, N., & Haitsam, M. (2023). Retinopati Diabetik: Patogenesis, Diagnosis, Tatalaksana Kini Dan Masa Depan. Jurnal Klinik dan Riset Kesehatan, 3(1), 18–32. http://dx.doi.org/10.11594/jk-risk.03.1.4
Vijaykumar, N., BK, H., Badiger, S., & Hegde, H. (2023). Effect of modifiable and non-modifiable risk factors on hypertension among diabetics: An observational study. National Journal of Physiology, Pharmacy & Pharmacology, 13(10). http://dx.doi.org/10.5455/njppp.2023.13.01002202307032023
Wallsh, J. O., & Gallemore, R. P. (2021). Anti-VEGF-resistant retinal diseases: a review of the latest treatment options. Cells, 10(5), 1049. https://doi.org/10.3390/cells10051049
Zhang, D., Wang, S., Li, M., Yao, X., Sun, Z., Zhang, C., Sun, S., et al. (2022). Prevalence and risk factors of diabetic retinopathy in Tibet. Chinese Journal of Primary Medicine and Pharmacy, 29(6), 835–840. https://doi.org/10.2147/DMSO.S378500
Copyright (c) 2025 Journal La Medihealtico
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
